InvestorsHub Logo
Followers 32
Posts 4083
Boards Moderated 1
Alias Born 06/08/2003

Re: None

Wednesday, 05/30/2007 9:29:20 AM

Wednesday, May 30, 2007 9:29:20 AM

Post# of 1211
We have a contract. See the paragraph that mentions Triton.

Gulf Biomedical Corporation Acquires 20 Additional Well Bores Initially Developed by Mobile Oil Company



Wednesday May 30, 6:00 AM EDT


HOUSTON, Texas, May 30, 2007 (BUSINESS WIRE) -- Gulf Biomedical Corporation (GBIC), a diversified conglomerate in the areas of oil and gas production and herbal products announces the acquisition of an oil, gas and mineral lease containing a fifty percent (50%) working interest in the I.T. Kent lease in Navarro County, Texas. The lease comprises over twenty existing well bores on approximately 88.34 acres.

The 20 well bores were initially developed by Mobil Oil Company as a part of Powell. This was the second most prolific Woodbine sand (2800+ ft.) in East Texas. The wells bores are located on the largest field in Navarro County. Potential production exists in the Nacatoch (500-600 ft.), Pecan Gap (1400 ft.) and Wolfe City (1700 ft).



Field management will be by Triton American Energy Corp. (TRAE), a specialist, in developing oil and gas properties Triton American Energy uses modern state of the art work-over and stimulation techniques.

About Gulf Biomedical Corporation:

Gulf Biomedical (GBIC) is a diversified company focused on generating residual revenue in high growth industries such as herbal products and oil and gas production. The Company herbal division targets the Erectile Dysfunction, Hair Restoration, Anti-Depression and Weight Loss segments. All products are created to be safe, reliable and backed by quality customer service. Gulf Biomedical's oil and gas division targets wells which can be worth hundreds of millions of dollars in revenue but require more hands-on attention then major producers are willing to give.

For more information on Gulf Biomedical or becoming an herbal distributor, please contact Investor Relations at (973) 351-3868.

To subscribe to receive updates on Gulf Biomedical's latest product developments or stock updates please visit the website at http://www.gulfbiomedicalgroup.com/ or www.Herbalstore.us.

Disclaimer: This news release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of l995 relating to aspects of the Company's operations and strategies. Important factors could occur to cause actual results to differ materially from those described herein. There is a risk that the Company may incur losses. Readers are urged to consider these cautionary statements carefully. Forward-looking statements speak only as of the date of this news release, and the Company disclaims any obligations to update such statements.

SOURCE: Gulf Biomedical Corporation


CONTACT: Gulf Biomedical Corporation

Investor Relations: Stephen Taylor, 973-351-3868 STEPHTAYL9@AOL.COM http://www.gulfbiomedicalgroup.com/ www.Herbalstore.us or Customer Service: 973-375-5002


Copyright Business Wire 2007


News provided by Comtex. Click here to view end user terms.

I am only expressing my personal opinions or repeating public information from SEC filings or media outlets-which may or may not be correct. Do your own investigating before investing!